ASX:RHY (Australia)  
Rhythm Biosciences Ltd logo

Rhythm Biosciences Ltd

A$ 1.18 (-2.08%) Sep 23
P/E:
At Loss
P/B:
34.55
Market Cap:
A$ 254.61M ($ 166.21M)
Enterprise V:
A$ 247.19M ($ 161.36M)
Volume:
109.03K
Avg Vol (2M):
113.56K
Volume:
109.03K
Market Cap A$:
254.61M
Market Cap $:
166.21M
PE Ratio:
At Loss
Avg Vol (2-Month):
113.56K
Enterprise Value A$:
247.19M
Enterprise Value $:
161.36M
PB Ratio:
34.55
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Rhythm Biosciences Ltd is a medical diagnostics technology company. It is engaged in developing and commercializing Australian medical diagnostics technology for sale to national and international markets. Its product includes ColoSTAT a proposed diagnostic blood test for screening for colorectal cancer. Geographically, the company operates only in Australia.
Name Current Vs Industry Vs History
Cash-To-Debt 44.42
Equity-to-Asset 0.87
Debt-to-Equity 0.02
Debt-to-EBITDA -0.02
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 9.79
9-Day RSI 21.74
14-Day RSI 30.97
6-1 Month Momentum % -5.07
12-1 Month Momentum % -2.96

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.34
Quick Ratio 8.34
Cash Ratio 8.15

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -20.6

Profitability Rank

Name Current Vs Industry Vs History
ROE % -183.31
ROA % -147.58
ROIC % -1409.27
ROC (Joel Greenblatt) % -7755.86
ROCE % -231.35

Financials

ASX:RHY's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$) 0
EPS (TTM) (A$) -0.042
Beta 2.82
Volatility % 75.08
14-Day RSI 30.97
14-Day ATR (A$) 0.049966
20-Day SMA (A$) 1.3125
12-1 Month Momentum % -2.96
52-Week Range (A$) 1.03 - 2.08
Shares Outstanding (Mil) 216.69

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Rhythm Biosciences Ltd Filings

Document Form Filing Date
No Filing Data

Rhythm Biosciences Ltd Analysis

Share your research